1 March 2023 - Anti-drug company activists are repeating ill-informed myths about controlling drug prices in Canada. ...
23 February 2023 - A member of the Patented Medicine Prices Review Board, Canada’s drug pricing regulator, has resigned over ...
15 February 2023 - Germany's health ministry on Tuesday vowed to fix shortages in medicines for children, antibiotics and cancer ...
2 February 2023 - The bloc’s pharma reform aims to get new drugs to patients faster, for less money. But it ...
19 January 2023 - The UK has a “voluntary scheme for branded medicines, pricing, and access” or VPAS, which sets a ...
16 January 2023 - AbbVie and Lilly have left the UK’s Voluntary Scheme for Branded Medicines Pricing and Access, a ...
28 November 2022 - The treatment will be made available immediately through an early access deal with NHS England. ...
15 November 2022 - Agreement to limit the size of the NHS drugs bill under strain. ...
10 November 2022 - Innovative Medicines Canada is calling on Health Canada to direct the Patented Medicine Prices Review Board (PMPRB) ...
4 November 2022 - Controversial amendments to the Patented Medicines Regulations changing the basket of comparator countries considered by the ...
1 November 2022 - From 1 November 2022, the PBS listings for certain medicines will be updated as part of the ...
26 October 2022 - On 1 September 2022, a Panel of the Patented Medicine Prices Review Board issued a decision that ...
27 October 2022 - The Australian Government’s legislation, which will see millions of Australians pay 29% less for scripts with the ...
26 October 2022 - The German regulation of pricing and reimbursement of pharmaceuticals is probably one of the most complicated legal ...
21 October 2022 - Amendments made by the National Health Amendment Act 2021 give effect to the commitments in the new ...